Table 1.
Result of Phenotypic Resistance Testing, IC50 | ||||||
---|---|---|---|---|---|---|
Sample Number | Subject | Site | Collection Date | Acyclovir | Foscarnet | Resistance Indicated by Genomic Analysis |
1 | Patient | Face | August, year 1 | Acyclovir | ||
2 | Patient | Right parietal scalp | August, year 1 | Acyclovir | ||
3 | Patient | Right parietal scalp | October, year 1 | I | R 101.6 | Acyclovir |
4 | Patient | Right parietal scalp | November, year 1 | R 10.6 | S 75.0 | Acyclovir |
5 | Patient | Eye | June, year 2 | I | I | |
6 | Patient | Scrotum | August, year 2 | Acyclovir, cidofovir | ||
7 | Patient | Scrotum | August, year 2 | R 11.1 | I | |
8 | Patient | Right parietal scalp | July, year 3 | R >64.0 | I | Acyclovir |
9 | Patient | Left occipital scalp | July, year 3 | Acyclovir | ||
10 | Patient | Lip | February, year 4 | S 1.7 | S 33.0 | |
11 | Patient | Lip | March, year 4 | Acyclovir | ||
12 | Patient | Lip | April, year 4 | R 3.1 | S 31.3 | |
Brother | Eye | March, year 4 | I | S 12.9 | Acyclovir |
Abbreviations: I, indeterminant; IC50, half maximal effective concentration; S, sensitive; R, resistant.